[go: up one dir, main page]

WO2009038089A1 - Anti-fatigue agent comprising sesamin and vitamin-e - Google Patents

Anti-fatigue agent comprising sesamin and vitamin-e Download PDF

Info

Publication number
WO2009038089A1
WO2009038089A1 PCT/JP2008/066766 JP2008066766W WO2009038089A1 WO 2009038089 A1 WO2009038089 A1 WO 2009038089A1 JP 2008066766 W JP2008066766 W JP 2008066766W WO 2009038089 A1 WO2009038089 A1 WO 2009038089A1
Authority
WO
WIPO (PCT)
Prior art keywords
vitamin
sesamin
fatigue agent
fatigue
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/066766
Other languages
French (fr)
Japanese (ja)
Inventor
Daisuke Takemoto
Yoshiko Ono
Yoko Yasutake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Holdings Ltd
Suntory Ltd
Original Assignee
Suntory Holdings Ltd
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd, Suntory Ltd filed Critical Suntory Holdings Ltd
Priority to JP2009533157A priority Critical patent/JP5794761B2/en
Publication of WO2009038089A1 publication Critical patent/WO2009038089A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Botany (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Disclosed is a composition which is highly safe for a human body or an animal and can be ingested continuously. The composition comprises sesamin and vitamin-E and has an anti-fatigue effect.
PCT/JP2008/066766 2007-09-19 2008-09-17 Anti-fatigue agent comprising sesamin and vitamin-e Ceased WO2009038089A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009533157A JP5794761B2 (en) 2007-09-19 2008-09-17 Anti-fatigue agent containing sesamin and vitamin E

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-243136 2007-09-19
JP2007243136 2007-09-19

Publications (1)

Publication Number Publication Date
WO2009038089A1 true WO2009038089A1 (en) 2009-03-26

Family

ID=40467899

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/066766 Ceased WO2009038089A1 (en) 2007-09-19 2008-09-17 Anti-fatigue agent comprising sesamin and vitamin-e

Country Status (2)

Country Link
JP (1) JP5794761B2 (en)
WO (1) WO2009038089A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2021065664A1 (en) * 2019-10-04 2021-04-08
CN114502157A (en) * 2019-10-04 2022-05-13 三得利控股株式会社 Composition for inhibiting decrease of muscle mass, preventing decrease, maintaining, recovering or increasing muscle mass

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04368326A (en) * 1991-06-15 1992-12-21 Suntory Ltd New composition
WO2004105749A1 (en) * 2003-05-27 2004-12-09 Suntory Limited Composition having autonomic nerve modulating activity and method of use thereof
WO2007119378A1 (en) * 2006-03-15 2007-10-25 Suntory Limited Composition containing riboflavin and sesamins

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04368326A (en) * 1991-06-15 1992-12-21 Suntory Ltd New composition
WO2004105749A1 (en) * 2003-05-27 2004-12-09 Suntory Limited Composition having autonomic nerve modulating activity and method of use thereof
WO2007119378A1 (en) * 2006-03-15 2007-10-25 Suntory Limited Composition containing riboflavin and sesamins

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DEVI, S. A. ET AL.: "Dietary vitamin E and physical exercise: I. Altered endurance capacity and plasma lipid profile in ageing rats", EXPERIMENTAL GERONTOLOGY, vol. 38, no. 3, 2003, pages 285 - 290 *
KEIICHI HIRAMOTO ET AL.: "Sanka Stress to Hiro", IGAKU NO AYUMI, vol. 204, no. 5, 2003, pages 309 - 313 *
MASAMI HARADA: "Sesamin no Seirikassei -Kosanka Sayo to Seitai Bogyo", BIO INDUSTRY, vol. 17, no. 3, 2000, pages 23 - 31 *
NOVELLI, G. P. ET AL.: "Spin-trappers and vitamin E prolong endurance to muscle fatigue in mice", FREE RADICAL BIOLOGY & MEDICINE, vol. 8, no. 1, 1990, pages 9 - 13 *
YOSUKE KATAOKA: "Sanka Stress to No no Hiro", IGAKU NO AYUMI, vol. 204, no. 5, 2003, pages 314 - 318 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2021065664A1 (en) * 2019-10-04 2021-04-08
CN114502157A (en) * 2019-10-04 2022-05-13 三得利控股株式会社 Composition for inhibiting decrease of muscle mass, preventing decrease, maintaining, recovering or increasing muscle mass
CN114514022A (en) * 2019-10-04 2022-05-17 三得利控股株式会社 Composition for maintaining living activity, preventing reduction, inhibiting or improving reduction thereof
EP4039329A4 (en) * 2019-10-04 2023-08-02 Suntory Holdings Limited Composition for suppression of decrease in muscle mass, prevention of decrease therein, maintenance thereof, recovery thereof or increase therein
JP2024098986A (en) * 2019-10-04 2024-07-24 サントリーホールディングス株式会社 Composition for maintaining, preventing, suppressing or improving decline in daily activity
TWI888414B (en) * 2019-10-04 2025-07-01 日商三得利控股股份有限公司 Use of compositions for maintaining, preventing, inhibiting or improving the amount of daily activity

Also Published As

Publication number Publication date
JPWO2009038089A1 (en) 2011-01-06
JP5794761B2 (en) 2015-10-14

Similar Documents

Publication Publication Date Title
PL2086642T3 (en) Dnase for the treatment of male sub-fertility
IL198289A (en) Substituted dihydropyrazolones, processes for their preparation, medicaments comprising them and their use for the preparation of such medicaments
EP2076198A4 (en) Inducing desirable temperature effects on body tissue
WO2007100535A3 (en) Oxyntomodulin derivatives
LT2227539T (en) Composition for human and/or animal nutrition, uses thereof and yeasts
EP2006284A4 (en) Dicyclooctane derivates, preparation processes and medical uses thereof
GB2443287B (en) Methods, compositions and formulations for the treatment of thyroid eye disease
CA121118S (en) Helicopter
IL197877A (en) Uses of aminomethyl-4-imidazole derivatives for the preparation of medicaments and medicaments comprising them
WO2008034013A3 (en) Medical devices and methods of making the same
IL207038A (en) Diazaspiro[5.5]undecane derivatives, pharmaceutical compositions comprising the same and uses thereof in the preparation of medicaments for treating or reducing the risk of an inflammatory disease or condition
MY147247A (en) Organic compounds and their uses
PL2057153T3 (en) (3-aryl-piperazin-1-yl) derivatives of 6,7-dialkoxyquinazoline, 6,7- dialkoxyphtalazine and 6,7-dialkoxyisoquinoline
IL198112A0 (en) 3-aminoimidazo [1,2-a]pyridine derivatives having an sglt1-and sglt2-inhibiting action for the treatment of type 1 and type 2 diabetes
IL216967B (en) 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives and use thereof for the treatment of diseases
WO2009040445A3 (en) Arabinoxylo-oligosaccharides useful against gastrointestinal infections
CA121119S (en) Helicopter
GB2452366B (en) An aid for the prevention of sudden infant death syndrome
WO2008046865A3 (en) Long-term feed - elderly
IL199168A0 (en) Indolizine derivatives and the use thereof as antidiabetics
PT1938684E (en) Use of polyoxymethylendialkylethers and/or dialdehydacetals for the preservation of human or animal bodies and compositions comprising the same
WO2009038089A1 (en) Anti-fatigue agent comprising sesamin and vitamin-e
EP2127668A4 (en) Enzyme composition and use thereof
ZA201005396B (en) 17-hydroxy-19-nor-21-carboxylic acid-steroid y-lactone derivative,use thereof,and medicament containing the derivative
WO2008112701A3 (en) G-substrate for the treatment and prevention of parkinson's disease

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08831590

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009533157

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08831590

Country of ref document: EP

Kind code of ref document: A1